Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients

Citation
A. Fritscher-ravens et al., Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients, AM J GASTRO, 95(9), 2000, pp. 2278-2284
Citations number
53
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN journal
00029270 → ACNP
Volume
95
Issue
9
Year of publication
2000
Pages
2278 - 2284
Database
ISI
SICI code
0002-9270(200009)95:9<2278:MLIPWO>2.0.ZU;2-O
Abstract
OBJECTIVE: Mediastinal lymphadenopathy (ML) is a cause for concern, especia lly in patients with previous malignancy. The investigation of choice is th oracic CT with a variable sensitivity and specificity requiring tissue diag nosis. We used endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA ) for cytodiagnosis of ML in patients with and without previous malignancy. The cause, distribution of lesions, and incidence of second cancers were i nvestigated. METHODS: Linear echoendoscopes and 22-gauge needles for cytology were used for EUS-FNA. A cytological diagnosis of malignancy was accepted, and histol ogy or consistent follow-up of at least 9 months confirmed benign results. RESULTS: One hundred fifty-three patients underwent EUS-FNA between Novembe r 1997 and November 1999 (mean age, 60 yr; range, 13-82 yr; 105 men). Cytol ogy was adequate in 150 patients. Final diagnosis was malignancy in 84 and benign in 66 patients (sensitivity, specificity, and diagnostic accuracy: 9 2%, 100%, 95%, respectively). In 101 patients without previous cancer cytol ogy identified 48 malignant (lung, 41; extrathoracic, 7) and 51 benign lesi ons (inflammation, 35; various, 9; sarcoidosis, 7) (sensitivity, specificit y, accuracy: 88%, 100%, 94%). Fifty-two patients had prior malignancy, most ly in extrathoracic sites. Cytology revealed recurrences in 21 patients, se cond cancer in 9 and benign lesions in 21 patients (inflammatory, 11; sarco idosis, 8; tuberculosis, 1; abscess, 1) (sensitivity, specificity, accuracy : 97%, 100%, 98%). CONCLUSIONS: In patients without previous cancer malignant ML originates fr om the lung >80%. In those with previous malignancy recurrence of extrathor acic sites is the major cause. Benign lesions and treatable second cancers occur in a significant frequency, emphasizing the need for tissue diagnosis . EUS-FNA is a safe and minimally invasive alternative for cytodiagnosis in the mediastinum. (Am J Gastroenterol 2000;95:2278-2284. (C) 2000 by Am. Co ll. of Gastroenterology).